Radiotherapy Market 2018-2023 New Investment Opportunities Emerge as Industry Segments Widen Says GE Healthcare, Siemens, Philips Healthcare etc.

“Radiotherapy Market”
Market Research Future has released a new report on the Global Radiotherapy Market which reveals a notable CAGR of 7% during the forecast period of 2018 to 2023 with an estimated value of USD 7 Million by the end of 2023. Report Contains detailed information to deliver country level analysis of the market’s segments which includes by treatment type and by applications.

Radiotherapy is generally used as a treatment for cancer. Around four out of every ten people are treated for cancer undergo radiotherapy. Normally together with other types of treatment including chemotherapy and surgery. Radiotherapy usually uses high power X-rays to destroy unwanted cells, such as cancer cells.

The Radiotherapy Market will grow very rapidly at a rate of 7% CAGR during the forecasted period 2017-2023. The market is expected to reach USD 7 million from 4.5 million in 2016 during the forecasted period.

Get Sample Report @

The focus of Radiotherapy is to destroy the unwanted cells and avoid damaging healthy cells as much as possible. The damages cell stops repairing itself when the cell is damaged through DNA and are broken down by the natural process of body. The radiotherapy treatment is less painful than the chemotherapy and surgeries. The radiotherapy also has some side effects along with it. The side-effects of radiation therapy are nausea, hair loss, skin problems, fatigue, appetite loss, diarrhea, fertility issues could potentially hamper radiotherapy devices market growth.

Global Radiotherapy Market – Major Players

Some of the players are involved in manufacturing of the Radiotherapy those are,

  • GE Healthcare (UK)
  • Siemens (Germany)
  • Varian (India)
  • Cardinal Health (US)
  • Nordion(CA)
  • Isoray(US)
  • View ray (US)
  • Fuji Holdings (Japan)
  • Philips Healthcare (US)
  • Shimadzu Corporation (Japan)
  • Hologic (US)

Global Radiotherapy Market – Updates

Feb 2018 the foremost international provider of innovative, superior quality and patient-centric radiotherapy solutions, CIVCO and Stratpharma AG which is a Swiss company that concentrates in pioneering topical medical products to progress post-procedure results, have joined their synergies to concentrate on wound care for patients in radiation therapy. This enterprise is in line with the missions of the two companies to emphasize on patient outcomes in the space for radiation therapy. CIVCO will be the special provider in the U.S. of the StrataXRT product which is a ground-breaking wound dressing in the treatment for dermatitis from radiation. Reactions which are acute and radiation-induced skin are an unavoidable result of radiation therapy and happen in up to 95% of patients getting treatment to the groin, breast or perineum. The StrataXRT is a gel which is a self-drying wound dressing is developed to be used through and after radiation treatment.

Global Radiotherapy Market – Segmentation

The segmentation for the radiotherapy market is done on the basis of the treatment type and by application. On the basis of treatment type includes X-Ray, Gamma ray, External Beam radiotherapy, proton therapy, internal radiation therapy. The external beam radiotherapy segment is further sub-segmented into the treatment types which are 3D conformal radiation therapy, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), Tomotherapy, Stereotactic radio surgery, and stereotactic body radiation therapy. On the basis of the application the segment is prostate cancer, breast cancer and lung cancer, ovarian cancer and thyroid.

Global Radiotherapy Market – Regional Analysis

The Radiotherapy Market is segmented into four main geographic regions Americas, Europe, Asia-Pacific, and Middle East and Africa. America holds the larger market in the radiotherapy the market increasing due to the increasing advancement in the technology. Europe is another dominating region for the use of the radiotherapy. Asia-pacific region is growing at a rapid pace because of the increasing number of patients in the region. The number is increasing due to the more consumptions of tobacco is seen in this region. Middle East and Africa is slow growing segment because of the lack of awareness of the chronic diseases and the treatment facilities are also limited in this region.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics


To Know More Enquire @

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India